Bioshares Newsletter “Biotech IPO Window: “Open” January 2011.

[Read more →]

The Australian Financial Review “Biotechs gear up to rival resources” January 2011.

[Read more →]

Genscreen announces that the in-house RESET project has completed initial testing and shall be renamed “Hervian”

[Read more →]

Ian Dixon, CEO of Genscreen Pty Ltd, announces that Genscreen is presently having TR400 drugs sythesised by a contractor. It is anticipated that screening results will be ready for review by March 2010

[Read more →]

Genscreen announces the interim results of its preclinical development projects

[Read more →]

Genscreen commences work with Qubist Molecular Design (www.qubistmd.com)

[Read more →]

Genscreen Pty Ltd announces that it has reduced its operations to concentrate on core activities

[Read more →]

Genscreen Pty Ltd is a privately-held company with a portfolio of 5 projects across therapeutic applications of cancer…

[Read more →]

Revision to Web site completed. The revised Genscreen web site reflects the broad…

[Read more →]

Genscreen announces the completion of the formation of Trobio Pty Ltd and the partnership with the Children’s Hospital at Westmead…

[Read more →]